June 8 (Reuters) – Johnson & Johnson said on Monday it will acquire biotech Firefly Bio for $1 billion in cash, as it looks to expand its cancer drug pipeline. (Reporting by Puyaan Singh in Bengaluru;
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Report: Hawks coach Quin Snyder gets multi-year extension
The Atlanta Hawks and head coach Quin Snyder have agreed to a multi-year contract extension,…
Fox to air NFL games in Mexico from 2026 season
June 8 (Reuters) - Fox will air National Football League games on its platforms in…
Italy's Bending Spoons, owner of AOL and Vimeo, files for Nasdaq IPO
By Arasu Kannagi Basil and Elvira Pollina BENGALURU/MILAN June 8 (Reuters) - Bending Spoons, an…
